Aerie Pharmaceuticals Inc. (AERI) News Nov 20, 201
Post# of 250601
Posted On: 11/21/2014 3:05:30 AM
Aerie Pharmaceuticals Inc. (AERI) News Nov 20, 2014, 5:14 p.m.
MarketWatch News on AERI
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Other News on AERI
10-Q: AERIE PHARMACEUTICALS INC 4:58 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aerie Pharmaceuticals' (AERI) CEO Vince Anido on Q3 2014 Results - Earnings Call Transcript 9:40 p.m. Nov. 11, 2014 - Seeking Alpha
Last patient completes treatment in Icon's Phase 3 for Verisome-based ocular therapy 9:44 a.m. Oct. 6, 2014 - Seeking Alpha
Bullish on Tech, Drug, Online Ed, and Solar 10:45 a.m. Sept. 29, 2014 - Barrons.com
Aerie Pharmaceuticals Inc. (AERI) CEO Vicente Anido on Q2 2014 Results - Earnings Call Transcript 6:24 p.m. Aug. 10, 2014 - Seeking Alpha
10-Q: AERIE PHARMACEUTICALS INC 3:49 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Dosing underway in Rhopressa Phase 3 8:46 a.m. July 14, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 7/11/14 1:10 a.m. July 13, 2014 - Seeking Alpha
Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape 7:44 a.m. July 10, 2014 - Zacks.com
Weakness Seen in TherapeuticsMD (TXMD): Stock Tumbles 8.4% - Tale of the Tape 7:34 a.m. July 10, 2014 - Zacks.com
Strength Seen in TherapeuticsMD, Inc. (TXMD): Stock Shoots 32.5% - Tale of the Tape 7:44 a.m. July 9, 2014 - Zacks.com
Why Auxilium Pharmaceuticals (AUXL) Could Be Positioned for a Slump? - Tale of the Tape 7:32 a.m. July 9, 2014 - Zacks.com
IntelliPharmaCeutics International (IPCI) Crumbles: Stock Plunges by 13.3% - Tale of the Tape 7:30 a.m. July 9, 2014 - Zacks.com
Tetraphase Pharmaceuticals (TTPH) Crumbles: Stock Tanks by 16.4% - Tale of the Tape 7:56 a.m. July 8, 2014 - Zacks.com
Can the Rally in Aerie Pharmaceuticals (AERI) Shares Continue? - Tale of the Tape 7:56 a.m. July 7, 2014 - Zacks.com
Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape 8:46 a.m. July 3, 2014 - Zacks.com
Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape 8:32 a.m. July 3, 2014 - Zacks.com
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 7:51 a.m. July 3, 2014 - Zacks.com
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape 8:46 a.m. July 2, 2014 - Zacks.com
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape 7:51 a.m. July 2, 2014 - Zacks.com
Press Releases on AERI
Aerie Pharmaceuticals to Present at the 2014 Stifel Nicolaus Annual Healthcare Conference 7:30 a.m. Nov. 12, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Business and Product Development Update 4:05 p.m. Nov. 11, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Announce Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 11, 2014 6:30 a.m. Oct. 28, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Elects Benjamin F. McGraw, III to Its Board of Directors 3:45 p.m. Oct. 6, 2014 - BusinessWire - BZX
Aerie Announces Closing of $125 Million Convertible Notes Financing 3:05 p.m. Sept. 30, 2014 - BusinessWire - BZX
Aerie Announces $125 Million Convertible Notes 5:27 a.m. Sept. 9, 2014 - BusinessWire - BZX
Deerfield Management Company Announces a $125 Million Facility with Aerie Pharmaceuticals 5:27 a.m. Sept. 9, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Host Investor Day on September 10, 2014 6:31 a.m. Sept. 4, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma 6:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Present at the Canaccord Genuity 34th Annual Growth Conference 6:30 a.m. Aug. 7, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business and Product Development Update 10:58 p.m. Aug. 6, 2014 - BusinessWire - BZX
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 10:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals, Inc. Receives Health Canada “No Objection Letter” to Commence Phase 3 Registration Trial of RhopressaTM in Patients with Glaucoma in Canada 6:32 a.m. July 24, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 2014 6:30 a.m. July 23, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Initiates Phase 3 Registration Trials of RhopressaTM, NovelTriple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 6:30 a.m. July 14, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 4:10 a.m. July 14, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals Expands Management Team, Names Michael McCleerey as Vice President, Marketing 3:05 p.m. July 7, 2014 - BusinessWire - BZX
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 3:05 p.m. June 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Announces Voting Results of 2014 Annual Meeting of Stockholders 3:05 p.m. June 11, 2014 - BusinessWire - BZX
MarketWatch News on AERI
Growth stocks provide litmus test for stock market 3:13 p.m. Nov. 18, 2014 - The Trading Deck
The double-edged sword of growth-stock speculation 2:30 p.m. Nov. 14, 2014 - The Trading Deck
Other News on AERI
10-Q: AERIE PHARMACEUTICALS INC 4:58 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
Aerie Pharmaceuticals' (AERI) CEO Vince Anido on Q3 2014 Results - Earnings Call Transcript 9:40 p.m. Nov. 11, 2014 - Seeking Alpha
Last patient completes treatment in Icon's Phase 3 for Verisome-based ocular therapy 9:44 a.m. Oct. 6, 2014 - Seeking Alpha
Bullish on Tech, Drug, Online Ed, and Solar 10:45 a.m. Sept. 29, 2014 - Barrons.com
Aerie Pharmaceuticals Inc. (AERI) CEO Vicente Anido on Q2 2014 Results - Earnings Call Transcript 6:24 p.m. Aug. 10, 2014 - Seeking Alpha
10-Q: AERIE PHARMACEUTICALS INC 3:49 p.m. Aug. 7, 2014 - Edgar Online - (EDG = 10Q, 10K)
Dosing underway in Rhopressa Phase 3 8:46 a.m. July 14, 2014 - Seeking Alpha
InsiderInsights.com Daily Round Up: 7/11/14 1:10 a.m. July 13, 2014 - Seeking Alpha
Aerie Pharmaceuticals, Inc. (AERI) in Focus: Stock up 8.37% - Tale of the Tape 7:44 a.m. July 10, 2014 - Zacks.com
Weakness Seen in TherapeuticsMD (TXMD): Stock Tumbles 8.4% - Tale of the Tape 7:34 a.m. July 10, 2014 - Zacks.com
Strength Seen in TherapeuticsMD, Inc. (TXMD): Stock Shoots 32.5% - Tale of the Tape 7:44 a.m. July 9, 2014 - Zacks.com
Why Auxilium Pharmaceuticals (AUXL) Could Be Positioned for a Slump? - Tale of the Tape 7:32 a.m. July 9, 2014 - Zacks.com
IntelliPharmaCeutics International (IPCI) Crumbles: Stock Plunges by 13.3% - Tale of the Tape 7:30 a.m. July 9, 2014 - Zacks.com
Tetraphase Pharmaceuticals (TTPH) Crumbles: Stock Tanks by 16.4% - Tale of the Tape 7:56 a.m. July 8, 2014 - Zacks.com
Can the Rally in Aerie Pharmaceuticals (AERI) Shares Continue? - Tale of the Tape 7:56 a.m. July 7, 2014 - Zacks.com
Alcobra (ADHD) Jumps: Stock Adds 5.9% in Session - Tale of the Tape 8:46 a.m. July 3, 2014 - Zacks.com
Jazz Pharmaceuticals Public Limited Company (JAZZ) in Focus: Stock Moves 6.9% Higher - Tale of the Tape 8:32 a.m. July 3, 2014 - Zacks.com
Zogenix, Inc. (ZGNX) Soars: Stock Adds 18.6% in Session - Tale of the Tape 7:51 a.m. July 3, 2014 - Zacks.com
Tesaro (TSRO) in Focus: Stock Moves 8.9% Higher - Tale of the Tape 8:46 a.m. July 2, 2014 - Zacks.com
Salix Pharmaceuticals (SLXP) Soars: Stock Adds 11.4% in Session - Tale of the Tape 7:51 a.m. July 2, 2014 - Zacks.com
Press Releases on AERI
Aerie Pharmaceuticals to Present at the 2014 Stifel Nicolaus Annual Healthcare Conference 7:30 a.m. Nov. 12, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Reports Third Quarter 2014 Financial Results and Provides Business and Product Development Update 4:05 p.m. Nov. 11, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Announce Third Quarter 2014 Financial Results and Host Conference Call on Tuesday, November 11, 2014 6:30 a.m. Oct. 28, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Elects Benjamin F. McGraw, III to Its Board of Directors 3:45 p.m. Oct. 6, 2014 - BusinessWire - BZX
Aerie Announces Closing of $125 Million Convertible Notes Financing 3:05 p.m. Sept. 30, 2014 - BusinessWire - BZX
Aerie Announces $125 Million Convertible Notes 5:27 a.m. Sept. 9, 2014 - BusinessWire - BZX
Deerfield Management Company Announces a $125 Million Facility with Aerie Pharmaceuticals 5:27 a.m. Sept. 9, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Host Investor Day on September 10, 2014 6:31 a.m. Sept. 4, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Inc. Initiates Phase 3 Safety-Only Registration Trial in Canada of RhopressaTM in Patients with Glaucoma 6:30 a.m. Sept. 3, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Present at the Canaccord Genuity 34th Annual Growth Conference 6:30 a.m. Aug. 7, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Business and Product Development Update 10:58 p.m. Aug. 6, 2014 - BusinessWire - BZX
Ophthalmic Drugs Market Forecast 2014-2024: Prospects for Leading Companies 10:55 a.m. Aug. 4, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals, Inc. Receives Health Canada “No Objection Letter” to Commence Phase 3 Registration Trial of RhopressaTM in Patients with Glaucoma in Canada 6:32 a.m. July 24, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals to Announce Second Quarter 2014 Financial Results and Host Conference Call on Wednesday, August 6, 2014 6:30 a.m. July 23, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Initiates Phase 3 Registration Trials of RhopressaTM, NovelTriple-Action Product to Lower Intraocular Pressure in Patients with Glaucoma 6:30 a.m. July 14, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 4:10 a.m. July 14, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals Expands Management Team, Names Michael McCleerey as Vice President, Marketing 3:05 p.m. July 7, 2014 - BusinessWire - BZX
Leadership Appointments, Acquisitions, Orphan Drug Designations, Strategic Collaborations, and Technical Updates - Analyst Notes on Aerie, Medical Action, INSYS, Novadaq and Foundation Medicine 5:10 a.m. June 30, 2014 - PR Newswire - PRF
Aerie Pharmaceuticals Names Craig R. Skenes as Vice President, Business Development 3:05 p.m. June 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Announces Voting Results of 2014 Annual Meeting of Stockholders 3:05 p.m. June 11, 2014 - BusinessWire - BZX
(0)
(0)Scroll down for more posts ▼